353 related articles for article (PubMed ID: 36535896)
1. Biomimicking Extracellular Vesicles with Fully Artificial Ones: A Rational Design of EV-BIOMIMETICS toward Effective Theranostic Tools in Nanomedicine.
Rosso G; Cauda V
ACS Biomater Sci Eng; 2023 Nov; 9(11):5924-5932. PubMed ID: 36535896
[TBL] [Abstract][Full Text] [Related]
2. Engineered extracellular vesicles as intelligent nanosystems for next-generation nanomedicine.
Fan Z; Jiang C; Wang Y; Wang K; Marsh J; Zhang D; Chen X; Nie L
Nanoscale Horiz; 2022 Jun; 7(7):682-714. PubMed ID: 35662310
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles.
Bai YT; Zhang XQ; Chen XJ; Zhou G
Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844
[TBL] [Abstract][Full Text] [Related]
4. Biogenesis, Membrane Trafficking, Functions, and Next Generation Nanotherapeutics Medicine of Extracellular Vesicles.
Gurunathan S; Kang MH; Qasim M; Khan K; Kim JH
Int J Nanomedicine; 2021; 16():3357-3383. PubMed ID: 34040369
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles for personalized medicine: The input of physically triggered production, loading and theranostic properties.
Piffoux M; Nicolás-Boluda A; Mulens-Arias V; Richard S; Rahmi G; Gazeau F; Wilhelm C; Silva AKA
Adv Drug Deliv Rev; 2019 Jan; 138():247-258. PubMed ID: 30553953
[TBL] [Abstract][Full Text] [Related]
6. EVs and Bioengineering: From Cellular Products to Engineered Nanomachines.
Villata S; Canta M; Cauda V
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842627
[TBL] [Abstract][Full Text] [Related]
7. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
Fais S; O'Driscoll L; Borras FE; Buzas E; Camussi G; Cappello F; Carvalho J; Cordeiro da Silva A; Del Portillo H; El Andaloussi S; Ficko Trček T; Furlan R; Hendrix A; Gursel I; Kralj-Iglic V; Kaeffer B; Kosanovic M; Lekka ME; Lipps G; Logozzi M; Marcilla A; Sammar M; Llorente A; Nazarenko I; Oliveira C; Pocsfalvi G; Rajendran L; Raposo G; Rohde E; Siljander P; van Niel G; Vasconcelos MH; Yáñez-Mó M; Yliperttula ML; Zarovni N; Zavec AB; Giebel B
ACS Nano; 2016 Apr; 10(4):3886-99. PubMed ID: 26978483
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles for drug delivery.
Vader P; Mol EA; Pasterkamp G; Schiffelers RM
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
[TBL] [Abstract][Full Text] [Related]
9. Dosing extracellular vesicles.
Gupta D; Zickler AM; El Andaloussi S
Adv Drug Deliv Rev; 2021 Nov; 178():113961. PubMed ID: 34481030
[TBL] [Abstract][Full Text] [Related]
10. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
[TBL] [Abstract][Full Text] [Related]
12. Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
Kooijmans SAA; de Jong OG; Schiffelers RM
Adv Drug Deliv Rev; 2021 Jun; 173():252-278. PubMed ID: 33798644
[TBL] [Abstract][Full Text] [Related]
13. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
Nasiri Kenari A; Cheng L; Hill AF
Methods; 2020 May; 177():103-113. PubMed ID: 31917274
[TBL] [Abstract][Full Text] [Related]
14. Engineered Extracellular Vesicles: Tailored-Made Nanomaterials for Medical Applications.
Man K; Brunet MY; Jones MC; Cox SC
Nanomaterials (Basel); 2020 Sep; 10(9):. PubMed ID: 32942556
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
Wu M; Wang M; Jia H; Wu P
Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.
Kim S; Maeng JY; Hyun SJ; Sohn HJ; Kim SY; Hong CH; Kim TG
Theranostics; 2020; 10(11):5011-5028. PubMed ID: 32308765
[TBL] [Abstract][Full Text] [Related]
17. Imaging as a tool to accelerate the translation of extracellular vesicle-based therapies for central nervous system diseases.
Gao Y; Chu C; Jablonska A; Bulte JWM; Walczak P; Janowski M
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1688. PubMed ID: 33336512
[TBL] [Abstract][Full Text] [Related]
18. Strategies to Enhance Extracellular Vesicle Production.
Hahm J; Kim J; Park J
Tissue Eng Regen Med; 2021 Aug; 18(4):513-524. PubMed ID: 34275103
[TBL] [Abstract][Full Text] [Related]
19. Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution.
Silva AM; Lázaro-Ibáñez E; Gunnarsson A; Dhande A; Daaboul G; Peacock B; Osteikoetxea X; Salmond N; Friis KP; Shatnyeva O; Dekker N
J Extracell Vesicles; 2021 Aug; 10(10):e12130. PubMed ID: 34377376
[TBL] [Abstract][Full Text] [Related]
20. Heterologous and cross-species tropism of cancer-derived extracellular vesicles.
Garofalo M; Villa A; Crescenti D; Marzagalli M; Kuryk L; Limonta P; Mazzaferro V; Ciana P
Theranostics; 2019; 9(19):5681-5693. PubMed ID: 31534511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
